albuterol has been researched along with Neuromuscular Diseases in 3 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Neuromuscular Diseases: A general term encompassing lower MOTOR NEURON DISEASE; PERIPHERAL NERVOUS SYSTEM DISEASES; and certain MUSCULAR DISEASES. Manifestations include MUSCLE WEAKNESS; FASCICULATION; muscle ATROPHY; SPASM; MYOKYMIA; MUSCLE HYPERTONIA, myalgias, and MUSCLE HYPOTONIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, NM | 1 |
| Hacohen, Y | 1 |
| Palace, J | 1 |
| Beeson, D | 1 |
| Vincent, A | 1 |
| Jungbluth, H | 1 |
| Wolfe, GI | 1 |
| Silvestri, NJ | 1 |
| Lynch, GS | 1 |
1 review available for albuterol and Neuromuscular Diseases
| Article | Year |
|---|---|
Therapies for improving muscle function in neuromuscular disorders.
Topics: Adjuvants, Immunologic; Adrenergic beta-Agonists; Albuterol; Aminoglycosides; Animals; Anti-Bacteria | 2001 |
2 other studies available for albuterol and Neuromuscular Diseases
| Article | Year |
|---|---|
Salbutamol-responsive fetal acetylcholine receptor inactivation syndrome.
Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Child, Preschool; Humans; Male; Neuromuscular Agents | 2016 |
Comment: Salbutamol--A means to an endplate.
Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Humans; Male; Neuromuscular Agents; Neuromuscular Di | 2016 |